APA (7th ed.) Citation

Chiu, H., Kuo, C., Lai, M., Wu, R., Chen, C., Chiu, C., . . . Le, P. Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: A real-world cohort study. BMC.

Chicago Style (17th ed.) Citation

Chiu, Horng-Yih, Chia-Jung Kuo, Ming-Wei Lai, Ren-Chin Wu, Chien-Ming Chen, Cheng-Tang Chiu, Yu-Bin Pan, Cheng-Hsun Chiu, and Puo-Hsien Le. Superior Persistence of Ustekinumab Compared to Anti-TNF in Vedolizumab-experienced Inflammatory Bowel Diseases Patients: A Real-world Cohort Study. BMC.

MLA (9th ed.) Citation

Chiu, Horng-Yih, et al. Superior Persistence of Ustekinumab Compared to Anti-TNF in Vedolizumab-experienced Inflammatory Bowel Diseases Patients: A Real-world Cohort Study. BMC.